ESMO Breast Cancer is an annual congress taking place for the first time on 2-4 May 2019 in Berlin, Germany. Brought to you by ESMO, your trusted provider of specialised education in oncology.
The 16th St. Gallen International Breast Cancer Conference 2019 in Vienna is less than seven months away.
Priming the Immune System: Neoadjuvant Durvalumab Plus Chemotherapy May Be Beneficial in Triple-Negative Breast Cancer
The International Scientific Committee and the local organizers invite to another (16th) outstanding «St. Gallen International Breast Cancer Conference» in Vienna, Austria, from 20-23 March 2019!
GeparNuevo Results of primary objective were presented at ASCO 2018: Durvalumab increases the pCR rate in TNBC patients.
Our Paper about PIK3CA-Mutations is one of the most-cited papers in JCO.
GBG Forschungs GmbHMartin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440
+49 6102 7480-0 | nfGBGd